Susquehanna International Group
TGTX icon

Susquehanna International Group’s TG Therapeutics TGTX Stock Holding History

Susquehanna International Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.1M Sell
544,720
-342,731
-39% -$10.2M ﹤0.01% 2356
2025
Q4 		$26.5M Buy
887,451
+179,120
+25% +$5.85M ﹤0.01% 1931
2025
Q3 		$25.6M Sell
708,331
-499,823
-41% -$16.5M ﹤0.01% 1949
2025
Q2 		$43.5M Buy
1,208,154
+548,494
+83% +$20.4M 0.01% 1261
2025
Q1 		$26M Sell
659,660
-167,445
-20% -$5.63M ﹤0.01% 1506
2024
Q4 		$24.9M Buy
827,105
+224,717
+37% +$6.45M ﹤0.01% 1682
2024
Q3 		$14.1M Sell
602,388
-484,681
-45% -$10.6M ﹤0.01% 2185
2024
Q2 		$19.3M Buy
1,087,069
+4,709
+0.4% +$75.1K ﹤0.01% 1764
2024
Q1 		$16.5M Sell
1,082,360
-866,297
-44% -$13.8M ﹤0.01% 2005
2023
Q4 		$33.3M Buy
1,948,657
+570,896
+41% +$6.63M 0.01% 1331
2023
Q3 		$11.5M Buy
1,377,761
+499,976
+57% +$6.97M ﹤0.01% 2374
2023
Q2 		$21.8M Sell
877,785
-400,463
-31% -$10.3M ﹤0.01% 1642
2023
Q1 		$19.2M Buy
1,278,248
+91,980
+8% +$1.4M ﹤0.01% 1753
2022
Q4 		$14M Buy
1,186,268
+153,296
+15% +$1.11M ﹤0.01% 1859
2022
Q3 		$6.12M Buy
1,032,972
+202,787
+24% +$1.33M ﹤0.01% 2856
2022
Q2 		$3.53M Sell
830,185
-154,244
-16% -$963K ﹤0.01% 3790
2022
Q1 		$9.36M Sell
984,429
-162,422
-14% -$1.88M ﹤0.01% 2629
2021
Q4 		$21.8M Sell
1,146,851
-491,930
-30% -$12.8M ﹤0.01% 1763
2021
Q3 		$54.5M Buy
1,638,781
+203,505
+14% +$6.3M 0.01% 1107
2021
Q2 		$55.7M Buy
1,435,276
+488,642
+52% +$19.2M 0.01% 1137
2021
Q1 		$45.6M Buy
946,634
+379,308
+67% +$18.2M 0.01% 1175
2020
Q4 		$29.5M Buy
567,326
+87,394
+18% +$2.95M ﹤0.01% 1388
2020
Q3 		$12.8M Buy
479,932
+271,474
+130% +$6.25M ﹤0.01% 1914
2020
Q2 		$4.06M Sell
208,458
-124,936
-37% -$2.01M ﹤0.01% 3301
2020
Q1 		$3.28M Buy
+333,394
New +$4.21M ﹤0.01% 3144
2019
Q4 		– Sell
-258,545
Closed -$1.97M – 10628
2019
Q3 		$1.45M Buy
258,545
+139,881
+118% +$975K ﹤0.01% 4896
2019
Q2 		$1.03M Sell
118,664
-406,539
-77% -$3.07M ﹤0.01% 5600
2019
Q1 		$4.22M Buy
525,203
+508,731
+3,088% +$2.75M ﹤0.01% 2661
2018
Q4 		$68K Buy
+16,472
New +$81.9K ﹤0.01% 8372
2018
Q3 		– Sell
-315,694
Closed -$3.61M – 10226
2018
Q2 		$4.15M Sell
315,694
-8,937
-3% -$123K ﹤0.01% 2958
2018
Q1 		$4.61M Sell
324,631
-61,125
-16% -$781K ﹤0.01% 2641
2017
Q4 		$3.16M Buy
385,756
+197,878
+105% +$1.73M ﹤0.01% 3151
2017
Q3 		$2.23M Sell
187,878
-63,804
-25% -$727K ﹤0.01% 3712
2017
Q2 		$2.53M Buy
251,682
+199,378
+381% +$2.23M ﹤0.01% 3464
2017
Q1 		$609K Sell
52,304
-26,943
-34% -$193K ﹤0.01% 6134
2016
Q4 		$368K Buy
79,247
+68,116
+612% +$399K ﹤0.01% 7580
2016
Q3 		$86K Sell
11,131
-18,892
-63% -$122K ﹤0.01% 8000
2016
Q2 		$182K Sell
30,023
-87,688
-74% -$713K ﹤0.01% 7677
2016
Q1 		$1M Sell
117,711
-20,794
-15% -$182K ﹤0.01% 5076
2015
Q4 		$1.65M Sell
138,505
-14,041
-9% -$177K ﹤0.01% 4423
2015
Q3 		$1.54M Buy
152,546
+19,425
+15% +$289K ﹤0.01% 4822
2015
Q2 		$2.21M Buy
133,121
+27,325
+26% +$433K ﹤0.01% 4499
2015
Q1 		$1.64M Buy
105,796
+12,837
+14% +$194K ﹤0.01% 4708
2014
Q4 		$1.47M Buy
92,959
+68,615
+282% +$893K ﹤0.01% 5075
2014
Q3 		$260K Sell
24,344
-21,865
-47% -$203K ﹤0.01% 8247
2014
Q2 		$434K Buy
46,209
+19,067
+70% +$122K ﹤0.01% 7753
2014
Q1 		$187K Buy
27,142
+9,697
+56% +$57.4K ﹤0.01% 8284
2013
Q4 		$68K Buy
+17,445
New +$70.5K ﹤0.01% 8736
2013
Q3 		– Sell
-12,407
Closed -$79K – 8766
2013
Q2 		$79K Buy
+12,407
New +$79.5K ﹤0.01% 7864

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's TGTX Position: Q1 2026 in Review

Susquehanna International Group reduced its TG Therapeutics (TGTX) stake by 39% in Q1 2026, selling an estimated $10.2M and leaving 544,720 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

Susquehanna International Group first reported a position in TGTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $55.7M in Q2 2021. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Susquehanna International Group held 544,720 shares of TG Therapeutics worth $18.1M as of Q1 2026.
  • Susquehanna International Group sold 342,731 TG Therapeutics shares in Q1 2026, an estimated $10.2M.
  • TG Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2356 holding.
  • Susquehanna International Group first reported a position in TG Therapeutics in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's TG Therapeutics position peaked at $55.7M in Q2 2021.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.